Marex Group plc (MRX) › Analysis

Marex Group plc (MRX) analysis, October 2, 2025

Published October 2, 2025 · MRX chart, levels and live analysis

Current Trend

Marex Group plc is in a steady downtrend across all time frames. The stock is down 8.83% on the day, 7.32% on the week and 13.32% over the past month, trading at $30.65. The six-month decline is 14.10%, while the stock is down just 1.67% year to date — a sign that the selling pressure has concentrated in recent months. The current price sits well below the analysts' target of $50, leaving a wide discount to fair value.

Investment Thesis

The thesis rests on strong operating results in Prime Services and growing recognition on Wall Street. The company posted 18% revenue growth in the second quarter, confirming the resilience of the business model. The consensus analyst forecast implies 43.92% upside, reflecting undervaluation at current levels. The core of the thesis is the company's ability to sustain growth in Prime Services.

Thesis Status

The thesis is under pressure following questions about the company's accounting practices. Allegations of off-balance-sheet transactions create reputational risk and could weigh on investor sentiment. Despite solid operating results, legal investigations are injecting uncertainty that could hold back the upside in the near term.

Key Drivers

The main positive driver is Prime Services operating performance, with revenue up 18% in the second quarter, supporting Barclays' bullish stance. The key negative is accounting allegations from NINGI Research, which have triggered investigations by multiple law firms. The analyst consensus points to 43.92% upside potential, creating a disconnect between the fundamental view and current market sentiment.

Technical Picture

The technical setup shows a persistent downtrend with the decline accelerating in the near term. The 8.83% one-day drop points to possible seller capitulation. The current level of $30.65 is far below analyst targets, which could provide technical support. The lack of any recovery over the past month signals weak buying interest and a need for fundamental catalysts to reverse the trend.

Bull Case

  • Strong 18% revenue growth in Prime Services in the second quarter shows the resilience of the business model (source)
  • The Wall Street consensus sees 43.92% upside, pointing to significant undervaluation (source)
  • Barclays reiterates a Buy rating with a $50 price target, 63% above current levels (source)
  • The company is recognized as one of the best new stocks to buy, reflecting business quality (source)
  • The current pullback could offer an attractive entry point for long-term investors once the legal issues are resolved (source)

Bear Case

  • Serious allegations of off-balance-sheet transactions from NINGI Research create reputational and regulatory risk (source)
  • Multiple legal investigations launched by several law firms could lead to significant costs and penalties (source)
  • The sustained 13.32% monthly decline points to fundamental concerns in investor perception (source)
  • Uncertainty over the outcome of the investigations could keep institutional money on the sidelines in the near term (source)
  • If the violations are confirmed, analyst estimates could be revised lower, pushing price targets down further (source)
Get a message when the MRX picture changes — the agent team watches the levels and the news for you.Create a free account

More MRX analyses